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Abstract Sirtuin 3 (Sirt3) is an NAD?-dependent mito-
chondrial deacetylase associated with superoxide dismu-
tase 2 (SOD2)-mediated protection from oxidative stress.
We have reported accelerated weight gain and impaired
metabolic flexibility in atherosclerotic Sirt3-/- mice.
Oxidative stress is a hallmark of endothelial dysfunction.
Yet, the role of Sirt3 in this context remains unknown.
Thus, we aimed to unravel the effects of endogenous Sirt3
on endothelial function and oxidative stress. Knockdown of
Sirt3 in human aortic endothelial cells (HAEC) increased
intracellular mitochondrial superoxide accumulation, as
assessed by electron spin resonance spectroscopy and flu-
orescence imaging. Endothelium-dependent relaxation of
aortic rings from Sirt3-/- mice exposed to a normal diet
did not differ from wild-type controls. However, following
12 weeks of high-cholesterol diet and increasing oxidative
stress, endothelial function of Sirt3-/- mice was mildly
impaired compared with wild-type controls. Relaxation was
restored upon enhanced superoxide scavenging using
pegylated superoxide dismutase. Knockdown of Sirt3 in
cultured HAEC diminished SOD2 specific activity, which
was compensated for by a CCAAT/enhancer binding pro-
tein beta (C/EBP-b)-dependent transcriptional induction of
SOD2. Abrogation of this feedback regulation by simul-
taneous knockdown of C/EBP-b and Sirt3 exacerbated
mitochondrial superoxide accumulation and culminated
into endothelial cell death upon prolonged culture. Taken
together, Sirt3 deficiency induces a mild, superoxide-de-
pendent endothelial dysfunction in mice fed a high-c-
holesterol diet. In cultured endothelial cells, a novel
C/EBP-b-dependent rescue mechanism maintains net
SOD2 activity upon transient knockdown of Sirt3.
Keywords Sirt3  Oxidative stress  SOD2  C/EBP-b 
Endothelial function
Introduction
Sirtuin 3 (Sirt3) is a mitochondrial deacetylase that regu-
lates mitochondrial oxidative metabolism and detoxifica-
tion from oxygen radicals [1, 3, 44, 58]. It is the third out of
seven mammalian homologues of the so-called class III
histone deacetylases (HDACs). They share a conserved
catalytic binding motif for the oxidized form of nicoti-
namide adenine dinucleotide (NAD?), defining them as
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class III HDACs and concentrating their activity to times of
low cellular energy levels [7, 9, 14, 19, 58]. Since its first
description in 1935, caloric restriction is the only inter-
vention that has been shown to prolong lifespan and
maintain mammalian health [25, 32, 47]. Mammalian sir-
tuins provide protective effects in a variety of age-related
pathologies, thus promoting healthy aging [7, 13, 23, 34].
Sirt3 is one out of two sirtuins that have been associated
with human longevity and health span [4, 15, 46]. Car-
diovascular diseases, including myocardial infarction and
stroke, are the leading global cause for age-related mor-
bidity and mortality, accounting for 17.3 million deaths a
year, with an estimated rise to[23.6 million by 2030 [2,
26].
Recently, Sirt3 deficiency has been reported to accel-
erate the development of the metabolic syndrome, a cluster
of hallmark risk factors for cardiovascular disease [18].
Although we did not observe an atherosclerotic phenotype
in low-density lipoprotein receptor knockout mice lacking
Sirt3, its loss was associated with accelerated weight gain,
impaired metabolic adaptation and increased levels of
systemic oxidative stress [55].
Excess endothelial reactive oxygen species (ROS),
subsequent mitochondrial DNA damage and progressive
respiratory chain dysfunction are essential in the develop-
ment of endothelial dysfunction, an early event in and an
independent predictor of cardiovascular disease [17, 28, 29,
33, 36, 40, 41, 48]. In numerous settings including
embryonic development, age-related hearing loss, neuronal
injury, and cardiac hypertrophy, Sirt3 has been shown to
protect from oxidative stress [10, 22, 49, 51]. In the
majority of settings, Sirt3 augmented superoxide scav-
enging by enhancing superoxide dismutase 2 (SOD2) and/
or catalase (cat) activity [42, 51, 53]. Whether increased
SOD2 activity is mediated by direct deacetylation or
transcriptional regulation remains controversial [51, 53].
Moreover, Sirt3 activates isocitrate dehydrogenase 2
(IDH2), which drives the tricarboxylic acid (TCA) cycle
and is a major donor of NADPH, an essential cofactor for
both glutathione regeneration and endothelial nitric oxide
synthase (eNOS)-mediated NO formation [31, 43, 44, 59].
Hitherto, only few data exist on the role of Sirt3 in arterial
endothelial cells [35]. No data are available on its effects
on endothelium-dependent vasodilation.
In contrast to the constitutive expression of the cytosolic
and extracellular isoforms SOD1 and SOD3, the inducible
expression of SOD2 allows the response to varying levels
of intracellular oxidative stress. The acetylation-dependent
transcription factor CCAAT/enhancer binding protein beta
(C/EBP-b) has been shown to bind an intronic TNF-re-
sponsive element of SOD2 and thereby facilitate SOD2
gene transcription in response to various stimuli associated
with increased levels of intracellular ROS [6, 21, 30].
Our goal was to unravel the effects of endothelial Sirt3
on oxidative stress and endothelial function, and to inves-
tigate the underlying mechanisms in human aortic
endothelial cells. To enhance oxidative stress in aortae, we
exposed mice to a high-cholesterol diet [37]. In the current
work, we uncovered a C/EBP-b-dependent induction of
SOD2 expression as rescue mechanism for the Sirt3-de-
pendent loss of SOD2 activity, an interaction, that until
to date remained unknown.
Methods
Mice
Mice were housed in a temperature-controlled facility with
a 12-h light/dark cycle and free access to chow and water.
All animal studies have been approved by the appropriate
ethics committee and have therefore been performed in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki and its later amendments. Mice
with a germline Sirt3 deletion were generated as described.
[12, 55] Congenic C57BL6/J Sirt3-/- mice were generated
through nine generations of backcrosses with C57BL6/J
mice. Eight-week-old male Sirt3-/- and wild-type mice
were fed a 1.25 % (w/w) cholesterol diet (research diets)
for 12 weeks and subsequently killed for fasted (unless
indicated otherwise) studies.
Endothelial function
Endothelium-dependent vasorelaxation was investigated as
described [37, 56]. Briefly, aortae were explanted and
aortic rings were obtained. Relaxation in response to
acetylcholine (ACh) or sodium nitroprusside (SNP) was
assessed using isometric force transducers in organ cham-
ber baths (Multimyograph, DMT). Maximal contraction
was defined before initiating the experiment using potas-
sium chloride (KCl) in a concentration of 80 mM. Pre-
contraction to a maximum of 70 % maximal contraction
was achieved using norepinephrine (NE) in a dose of
10-7 M. Dose–response curves were quantified comparing
areas under the curves (AUC).
Cell culture and transfection
Human aortic endothelial cells (HAEC, Cambrex) from
passage three to eight were grown to confluence at 5 %
CO2 and 37 C in Endothelial Growth Medium 2 (Lonza)
supplemented with 10 % fetal calf serum. Transient
knockdown was performed using Lipofectamine Reagent
(Life Technologies) for transfection of the following small
interference RNA (siRNA): Sirt3 (50-GCC CAA CGU
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CAC UCA CUA CUU TT-30), C/EBP-b (Trilencer-27
siRNA, OriGene), SOD2 (50-AAU GCU ACA AUA GAG
CAG CUU TT-30), scrambled (50-UUC UCC GAA CGU
GGC ACG ATT-30), Trilencer-27 Universal Scrambled
Negative Control siRNA (SR30004, Origene), and Silencer
Negative Control #5 siRNA (AM4642, Ambion). Total
siRNA amounts were kept equal among all experiments.
Where two-stage transfections (double-knockdown of Sirt3
and C/EBP-b) were performed, all groups in the respective
experiments were transfected twice. Knockdown efficiency
was assessed using expression analyses on RNA- (quanti-
tative PCR) and protein level (western blot).
Expression analyses
RNA isolation, reverse transcription and SYBR green-
based (Applied Biosystems) quantitative PCR was carried
according to standard protocols using a Quant Studio 7
Flex Real Time PCR thermocycler (Applied Biosystems)
with the associated sequence detection system and soft-
ware. Expression was calculated using the DDCT method.
Relative gene expression was normalized to b-actin
(house-keeping gene). Western blot analyses of HAEC
lysates were conducted according to standard protocols
using the following specific antibodies:
anti-Sirt3 (rabbit monoclonal, Cell Signalling Technol-
ogy), anti-C/EBP-b [C19] (rabbit polyclonal, Santa Cruz
Biotechnology), anti-SOD2 (rabbit polyclonal, Abcam),
anti-catalase (mouse monoclonal, Sigma), anti-glutathion
peroxidase 1 (rabbit polyclonal, Novus Biologicals), anti-
total eNOS (mouse polyclonal, BD Transduction Labora-
tories), anti-eNOS (pThr495) (mouse, monoclonal, BD
Transduction Laboratories), anti-eNOS (pSer1177)
(mouse, monoclonal, BD Transduction laboratories), anti-
xanthine oxidase (rabbit polyclonal, Biorbit), anti-NADPH
oxidase subunit p22phox (rabbit polyclonal, Biorbit), and
anti-b actin (mouse monoclonal, Sigma-Aldrich). Specific
signals were detected using species-specific secondary
antibodies.
Immunoprecipitation
HAEC were cultured in 10 cm cell culture dishes, trans-
fected as described above and lysed in 1 ml radioim-
munoprecipitation assay (RIPA) buffer. Samples were kept
on ice throughout IP steps. The lysates were pre-cleared
with 30 ll washed Protein G Agarose beads (Millipore)
and, after removal of the beads, incubated over night with
suitable monoclonal antibodies for SOD2, C/EBP-b or Sp1,
respectively. 30 ll of washed Protein G Agarose beads
were added and the mixture was incubated for 4.5 h with
agitation on the incubation wheel. Beads–antibody–antigen
complexes were separated from the lysates by
centrifugation and the pellet washed three times with RIPA
buffer. After adding 30 ll of 49 Laemmli buffer, the
samples were incubated at 60 C with shaking for 10 min
and the supernatant resulting from subsequent centrifuga-
tion was analyzed by western blotting.
The following antibodies were used for immunoprecip-
itation and subsequent determination of the acetylation or
nitrosylation status, respectively: anti-SOD2 [1E8] (mouse
monoclonal, Abnova), anti-acetyl lysine (rabbit polyclonal,
Chemicon), and anti-nitro tyrosine [HM.11] (mouse mon-
oclonal, Abcam).
Electron spin resonance spectroscopy
Intracellular superoxide in HAEC was detected by electron
spin resonance (ESR) spectroscopy using the superoxide-
specific spin trap 1-hydroxy-3-methoxy-2,2,5,5-tetra-
methylpyorrolidine (CMH, Noxygen) as described [50, 57].
Mitochondrial superoxide detection
Mitochondrial superoxide generation was investigated
based on the oxidation and fluorogenic nucleic acid binding
of a mitochondrial- and superoxide-specific probe (Mi-
toSOXTM, Invitrogen). Cells were stained according to the
manufacturer’s protocol and fixed with 4 %
paraformaldehyde afterwards. Fluorescence was quantified
using an Olympus BX51 microscope. Micrographs were
quantified using ImageJ (NIH).
Scavenging of mitochondrial superoxide
HAEC were handled and transfected as described above.
Upon transfection with siRNA the medium was supple-
mented with 1 lM mitoTEMPO (Sigma). Medium was
replaced with fresh EGM-2 medium containing 1 lM
mitoTEMPO once, before harvesting the lysates for
expression analyses or staining the cells for fluorescence
imaging.
Superoxide dismutase 2 (SOD2) activity
Mitochondrial fractions of HAEC were separated from
whole cell lysates by centrifugation. Enzymatic activity of
SOD2 in HAEC was assessed based on its capacity to
dismutate superoxide radicals generated by xanthine oxi-
dase under controlled conditions, using the Superoxide
Dismutase Assay Kit (Cayman Chemical). Superoxide
radicals were detected by colorimetric oxidation of tetra-
zolium salt to formazan dye. Any remaining activity of
SOD1 and 3 was inhibited using potassium cyanide
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(1 mM) according the manufacturer’s instructions. Enzy-
matic activity was normalized to SOD2 protein expression.
Nitric oxide production
HAEC were seeded into a 96 well plate and transfected as
described above. At time of the assay, cells were incubated
with Krebs buffer containing 0.25 lM 4,5-diaminofluo-
rescein diacetate (DAF-2, Sigma) in presence or absence
of 10 lM of the unspecific nitric oxide synthase (NOS)
inhibitor L-N5-(1-Iminoethyl)ornithine hydrochloride
(L-NIO, Sigma), or 0.25 lM of the DAF-2 negative control
4-aminofluorescein diacetate (4-AF-DA, Merck Millipore),
respectively, for 20 min at 37 C. Then L-arginine with or
without calcium-ionophore (positive control) was added to
the wells and fluorescence read at 490/525 nm (excitation/
emission) to set the baseline. After 30 min the fluorescence
was measured again and the percentage of nitric oxide
increase calculated.
Statistics
Metric variables were assessed for distribution using Kol-
mogorov–Smirnov tests. For n\ 4 non-parametric distri-
bution was assumed. Different groups were compared
using unpaired Student’s t, Mann–Whitney, one-way
ANOVA tests with Bonferroni multiple comparison post
hoc tests or Kruskal–Wallis tests with Dunn’s post hoc
analyses, where applicable. p values are two-sided. Sig-
nificance was accepted for an alpha-error\0.05. Data are
presented as mean ± SEM, if not indicated otherwise.
Statistical analyses were performed using GraphPad Prism
5 for Mac OS X (GraphPad Software).
Results
Transient knockdown of Sirt3 increases endothelial
superoxide levels
siRNA-mediated transient knockdown of Sirt3 in human
aortic endothelial cells (HAEC) reached an efficiency of
81 % on RNA- and 87 % on protein level (Fig. 1a).
Intracellular superoxide levels were increased two-fold
upon knockdown of Sirt3, as quantified using electron spin
resonance spectroscopy (Fig. 1b). With Sirt3 being a
mitochondrial deacetylase we used a mitochondrial- and
superoxide-specific probe (MitoSOXTM) to identify the
cellular compartment of increased superoxide. Fluores-
cence imaging revealed a two-fold increase in mitochon-
drial superoxide levels, identifying mitochondria as the
source of increased oxidative stress during transient
knockdown of Sirt3 (Fig. 1c).
Loss of Sirt3 is associated with a mild superoxide-
dependent impairment of endothelial function
To assess the functional relevance of elevated endothelial
superoxide levels in the absence of Sirt3, aortic rings of
Sirt3-/- and wild-type mice were explanted and endothe-
lium-dependent relaxation was quantified in organ chamber
baths. Surprisingly, aortic relaxation of Sirt3-/- mice in
response to acetylcholine (ACh) was unaltered compared
with wild-type controls (Fig. 2a). However, upon 12 weeks
of high-cholesterol diet, known to increase oxidative stress
[33], aortic relaxation of both genotypes was less sensitive
to ACh at low dosages and showed an overall mild
impairment in aortae of Sirt3-/- mice compared to wild-
type controls (Fig. 2b). Scavenging endogenous superoxide
by an excess of exogenous pegylated superoxide dismutase
(PEG-SOD) improved the sensitivity to ACh of either
genotype and abolished the impairment of aortic relaxation
of high-cholesterol diet-fed Sirt3-/- mice compared to
wild-type controls (Fig. 2c). ACh-induced aortic relaxation
in both genotypes could be prevented by preincubation
with the endothelial nitric oxide synthase (eNOS) inhibitor
L-nitroarginine methyl ester (L-NAME), indicating
endothelial NO-dependency (Fig. 2d, S1C). Concomi-
tantly, complete relaxation of aortae of both genotypes in
response to the exogenous NO donor sodium nitroprusside
(SNP) further underlined endothelium-derived NO-depen-
dency (Fig S1A, B). Of note, there was no significant
difference in body weight between wild-type and Sirt3-/-
mice (Fig S2). These findings suggest a mild, superoxide-
dependent decline in aortic relaxation in the absence of
Sirt3 upon a high-cholesterol diet.
Endothelial SOD2-specific activity is diminished
whereas SOD2 expression is increased following
transient knockdown of Sirt3
To unravel the mechanism underlying increased endothe-
lial mitochondrial superoxide levels upon Sirt3 deficiency,
we addressed SOD2-specific activity. Following transient
knockdown of Sirt3 in HAEC, superoxide scavenging
capacity of SOD2 was reduced by threefold compared with
controls (Fig. 3a). Unexpectedly, expression levels of
SOD2 were increased by 4.4 fold on RNA- and by 2.8 fold
on protein level, respectively (Fig. 3c), thus compensating
for the Sirt3-dependent loss of SOD2 specific activity;
overall endothelial SOD2 activity, without normalizing to
protein levels, was unchanged upon transient knockdown
of Sirt3 (Fig. 3b). Decreased SOD2-specific activity was
associated with a trend towards SOD2 hyperacetylation
(Fig. 3d). SOD2 nitrosylation was unchanged upon
knockdown of Sirt3 (Fig. 3e), suggesting a Sirt3-depen-
dent, deacetylation-mediated activation of endothelial
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SOD2 under physiological conditions. Expression levels of
other superoxide scavenging or decomposing enzymes,
including SOD1, SOD3, catalase, thioredoxin 1, thiore-
doxin 2, thioredoxin-dependent peroxide reductase
(PRDX3), and glutathione peroxidase were unaltered
(Fig. 3f–h, Fig S3A–E). Accordingly, the expression level
of endothelial superoxide-generating enzyme NADPH
oxidase was unaffected by transient knockdown of Sirt3
(Fig S3F, G). Whereas no difference occurred in the
cytosolic subunit p47phox (Fig S3F), we observed a slight
increase in the mRNA level of the membrane-bound sub-
unit p22phox, which did not translate into an increased
protein level (Fig S3G).
Nitric oxide generation is not affected by Sirt3
deficiency
Assessment of endothelial nitric oxide synthase (eNOS)
uncovered unaltered overall expression levels (Fig S4A)
and unchanged phosphorylation at Ser1177 (Fig S4B) upon
Sirt3 knockdown. However, we observed a decreased
phosphorylation of Thr495 following transient knockdown
of Sirt3 (Fig S4C), equivalent to an increased enzymatic
activity. Together with an increased coupling of eNOS
monomers (Fig S4D) this may be a compensatory effect
secondary to an increased mitochondrial ROS accumula-
tion upon Sirt3 deficiency. To assess the functional rele-
vance of increased eNOS activity, nitric oxide (NO)
generation was assessed in presence or absence of L-NIO,
an unselective nitric oxide synthase inhibitor, using DAF-2
diacetate. L-NIO successfully reduced NO generation,
however, no significant difference was observed upon
transient knockdown of Sirt3 compared with controls,
neither in presence nor in absence of L-NIO (Fig S4E).
Thus, increased eNOS activity upon Sirt3 deficiency does
not generate a detectable rise in NO. Nonetheless,
increased eNOS coupling may contribute to counteract
increased ROS levels upon Sirt3 deficiency.
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Fig. 1 Transient knockdown of Sirt3 increases endothelial superox-
ide levels. a Quantitative PCR of mRNA (left) and western blot
analyses of protein (right) isolated from human aortic endothelial
cells (HAEC) following siRNA-mediated knockdown of Sirt3.
b Electron spin resonance (ESR) spectroscopy of live HAEC
following siRNA-mediated knockdown of Sirt3 to quantify intracel-
lular superoxide release. c Fluorescence imaging of HAEC following
siRNA-mediated knockdown of Sirt3 and detection of mitochondrial
superoxide (red) using MitoSOXTM, a mitochondrial- and superoxide-
specific probe; quantification on a per cell basis; representative
micrographs show nuclei (blue) and mitochondrial superoxide (red,
MitoSOXTM); scale bars 20 lm. At least three independent exper-
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Transcriptional induction of SOD2 upon transient
knockdown of Sirt3 is C/EBP-b-dependent
To shed light on the unexpected transcriptional upregula-
tion of endothelial SOD2 during transient knockdown of
Sirt3, we assessed the expression levels of known, acety-
lation-dependent transcription factors of SOD2. Expression
levels of Sp1 and STAT3 were unaffected by transient
knockdown of Sirt3 (Fig. 4a, b), whereas expression of
CCAAT/enhancer binding protein beta (C/EBP-b) was
increased (Fig. 4c).
This differential expression in response to decreased
Sirt3 levels prompted us to address the relevance of
C/EBP-b in the transcriptional induction of SOD2 during
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Fig. 3 Loss of Sirt3 decreases
endothelial SOD2 activity and
increases SOD2 expression
without affecting other ROS-
scavenging or generating
systems. a Superoxide
dismutase 2 (SOD2) activity
based on superoxide
dismutating capacity in HAEC
following siRNA-mediated
knockdown of Sirt3; enzymatic
activity was normalized to
SOD2 protein expression;
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transient knockdown of Sirt3. Interestingly, simultaneous
knockdown of Sirt3 and C/EBP-b abrogated the tran-
scriptional upregulation of SOD2, whereas single knock-
down of C/EBP-b had no effect on SOD2 expression levels
compared with controls (Fig. 4d–g).
Transcriptional induction of C/EBP-b is SOD2-
dependent
To assess the role of SOD2 on the transcriptional induction
of C/EBP-b we used a loss-of-function approach in HAEC.
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Fig. 4 Transcriptional induction of SOD2 upon transient knockdown
of Sirt3 is C/EBP-b-dependent. a–d Expression analyses of the
transcription factors a Sp1, b STAT3, c, d C/EBP-b using quantitative
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Transient knockdown of SOD2 was associated with a sig-
nificant increase in C/EBP-b transcription on RNA-level
(Fig S5A), which translated into a trend towards increased
protein levels of C/EBP-b (Fig S5B), indicating the exis-
tence of a direct feedback loop between SOD2 and its
transcription factor C/EBP-b in endothelial cells. Sirt3
expression was unaltered (Fig S5 F, G).
Scavenging mitochondrial superoxide does not affect
Sirt3-dependent transcriptional induction of SOD2
To investigate whether SOD2 induction upon Sirt3 defi-
ciency is superoxide-dependent, mitochondrial superoxide
was scavenged using the mitochondrial-targeted superox-
ide scavenger mitoTEMPO. Mitochondrial superoxide
accumulation following knockdown of Sirt3 in HAEC was
successfully blunted by mitoTEMPO, as assessed by flu-
orescence imaging after MitoSOX staining (Fig. 5a–c).
Interestingly, SOD2 induction upon Sirt3 knockdown was
unaffected by blunting mitochondrial superoxide accu-
mulation (Fig. 5d). Transcriptional upregulation of
C/EBP-b following knockdown of Sirt3 was also unal-
tered upon scavenging of mitochondrial superoxide
(Fig. 5e). Translation to increased protein levels could not
be observed, independent of mitochondrial superoxide
(Fig. 5f).
Interruption of the physiological C/EBP-b-
dependent feedback regulation of endothelial SOD2
exacerbates mitochondrial superoxide levels
and culminates in endothelial cell death
To reveal the functional relevance of the C/EBP-b-depen-
dent transcriptional feedback regulation of endothelial
SOD2 upon Sirt3 deficiency, we assessed mitochondrial
superoxide levels following single or simultaneous
knockdown of C/EBP-b and Sirt3, respectively, compared
with sham-transfected controls. Concomitant with the
abrogation of the transcriptional induction of SOD2 fol-
lowing simultaneous knockdown of C/EBP-b and Sirt3,
mitochondrial superoxide levels were further enhanced
compared with single-knockdown controls (Fig. 6a, b).
Transient knockdown of C/EBP-b alone had no effect on
mitochondrial superoxide levels (Fig. 6a, b). Interestingly,
we observed an increased cell death upon prolonged cul-
tivation (40 h) following simultaneous knockdown of
C/EBP-b and Sirt3 that occurred in none of the control
conditions (Fig. 6c, d): Incubation for up to 40 h following
knockdown led to a demise of the majority of cells
(Fig. 6d), which we interpret as the consequence of
increased oxidative stress.
Discussion
Principle findings
We identify Sirt3 as an important player in the homeostasis
of endothelial mitochondrial superoxide. Under physio-
logical conditions, endogenous endothelial Sirt3 appears to
uphold SOD2 activity by maintaining its deacetylation for
effective degradation of mitochondrial superoxide and
thereby preserving normal endothelial function. Lack of
Sirt3 is associated with a hyperacetylation of SOD2. A
concomitant loss of SOD2 activity is, however, compen-
sated for by a C/EBP-b dependent induction of SOD2
expression. The latter occurs independent of mitochondrial
superoxide accumulation, yet potentially upon an initial
transcriptional repression of SOD2 upon Sirt3 deficiency.
Consequently, endothelial function is maintained under
normal circumstances. Only upon a high-cholesterol diet,
leading to increased oxidative stress, a mild, superoxide-
dependent impairment of endothelial function can be
unmasked. In vitro experiments in human aortic endothelial
cells indicate that this may be due to an accumulation of
mitochondrial superoxide secondary to a residual moderate
imbalance of mitochondrial superoxide generation and
detoxification. Since none of the superoxide scavenging or
generating enzymes assessed were altered upon Sirt3
deficiency, we extrapolate that impaired mitochondrial
function upon Sirt3 deficiency [38, 54] may increase
mitochondrial superoxide formation.
Added value
Anti-oxidative effects of Sirt3 have been described in a
variety of contexts including age-related hearing loss [49],
embryogenesis [22], neuronal injury [10], exercise training
[27], and cardiac hypertrophy [51]. In the majority of these
settings, the protective effects of Sirt3 are mediated by an
augmented radical scavenging through SOD2 and/or cata-
lase. It remains controversial whether these effects are
brought about by a transcriptional induction of either of
these two ROS detoxification systems or by their Sirt3-
dependent deacetylation and consecutive activation [8, 42,
51].
In the present study, we report on the role of endogenous
Sirt3 in human aortic endothelial cells and its functional
effects on endothelium-dependent vasodilation in a mouse
model applying a genetic loss-of-function approach. Cor-
roborating previous reports on anti-oxidative effects of
Sirt3 [42], transient knockdown of endothelial Sirt3 abro-
gated the superoxide scavenging capacity of SOD2 and
increased its acetylation.
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In contrast to previous data [51], we observed that
transcription of endothelial SOD2 was not reduced but
enhanced following transient knockdown of Sirt3,
compensating for its decreased enzymatic activity. How-
ever, an initial transcriptional repression of SOD2 upon
Sirt3 deficiency, preceding the C/EBP-b dependent
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Fig. 5 Scavenging mitochondrial superoxide does not affect Sirt3-
dependent transcriptional induction of SOD2. a Quantification of
mitochondrial superoxide per cell, as visualized by MitoSOXTM
staining, using fluorescence imaging of HAEC following transient
knockdown of Sirt3 or transfection with scrambled siRNA (scr) in
presence or absence of the mitochondrial-targeted anti-oxidant
mitoTEMPO. b Representative micrographs of the setup described
in a, showing nuclei (blue, DAPI) and mitochondrial superoxide (red,
MitoSOXTM). c, d, f Quantification of western blot analyses of Sirt3
(c), SOD2 (d), and C/EBP-b (f). e quantitative PCR of C/EBP-b. At
least three independent experiments in biological triplicates were
performed. Scale bars 20 lm, DAPI 40-6-diamidin-2-phenylindol, n.s.
non-significant, **p\ 0.01, ***p\ 0.001
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transcriptional induction of SOD2 cannot be excluded.
Even though the drop in endothelial SOD2 activity upon
Sirt3 deficiency slightly exceeded its transcriptional
increase, we extrapolate that an excess in mitochondrial
superoxide generation secondary to a Sirt3-dependent
impairment of mitochondrial function [38] may contribute
to the disequilibrium between mitochondrial superoxide
generation and detoxification. Of note, expression levels of
other endothelial ROS and reactive nitrogen species
detoxification systems, including catalase and the thiore-
doxin system, were unaffected by transient knockdown of
Sirt3. Therefore, a thioredoxin-mediated transcriptional
induction of SOD2, as reported in yeast and primary human
lung microvascular endothelial cells [11, 39] appears
unlikely. Assessment of endothelial nitric oxide synthase
(eNOS) uncovered a decreased phosphorylation of Thr495
as well as an increased coupling following transient
knockdown of Sirt3, equivalent to an increased enzymatic
activity [43, 52]. Importantly, NO generation remained
unchanged, indicating that increased activity remains
functionally irrelevant with regard to NO homeostasis.
However, increased eNOS coupling may contribute to
counteract increased ROS levels upon Sirt3 deficiency.
Moreover, our in vitro experiments identify mitochon-
dria as the compartment exhibiting increased ROS in the
absence of endothelial Sirt3, a finding, for which to date
only indirect evidence exists [22, 54].
Elegant promoter studies identified that C/EBP-b is
necessary to align with an intronic enhancer of SOD2 to
facilitate its transcription in response to increased levels of
intracellular ROS [6, 21, 30]. The differential regulation of
C/EBP-b in response to transient Sirt3 knockdown and its
acetylation-dependent binding capacity [6] prompted us to
investigate the role of C/EBP-b in the transcriptional reg-
ulation of SOD2 in the absence of endothelial Sirt3.
Abrogation of SOD2 induction upon simultaneous knock-
down of both Sirt3 and C/EBP-b exacerbated mitochon-
drial superoxide accumulation and culminated in
endothelial cell death after prolonged cultivation. Inter-
estingly, we observed a bidirectional feedback regulation
between C/EBP-b and SOD2 with an SOD2-dependent
transcriptional induction of C/EBP-b and vice versa. This
might indicate that an initial transcriptional repression of
SOD2 upon Sirt3-deficiency, as has been reported by oth-
ers [20, 24, 45, 51], in addition to a blunted SOD2 activity,
may have preceded C/EBP-b dependent transcriptional
induction of SOD2. Importantly, transcriptional induction
of C/EBP-b was independent of mitochondrial superoxide.
These findings highlight the functional relevance of this
novel C/EBP-b-dependent transcriptional induction of
SOD2 in absence of Sirt3 in human aortic endothelial cells.
The ex vivo assessment of endothelium-dependent
vessel relaxation showed a rather atypically shaped
relaxation curve; the initial sigmoidal shape is interrupted
by a weak contraction, starting at acetylcholine levels
around 1 lM, before reaching complete relaxation at
100 lM. Interestingly, this intermittent contraction was
exacerbated in mice fed a high-cholesterol diet. This and
the fact that this phenomenon disappeared in presence of
PEG-SOD indicate that this intermittent contraction in
response to higher acetylcholine dosages is an oxidative
stress-dependent phenomenon, as we have observed pre-
viously [60].
Potential limitations
This study has to be interpreted in light of the following
limitations: The difference in endothelium-dependent
vasorelaxation between the two genotypes is mild. How-
ever, rescue of this phenotype by scavenging of superoxide
via exogenous pegylated superoxide dismutase proves
superoxide-dependency. Furthermore, improvement of the
sensitivity to ACh of both genotypes upon enhanced
superoxide scavenging highlights the tight regulation of
endothelial function by superoxide and NO and stresses the
physiological relevance of Sirt3 and C/EBP-b in regulation
of endothelial SOD2 activity and thus of endothelial
function.
In light of the C/EBP-b dependent transcriptional
compensation of the Sirt3-dependent loss of SOD2 activity
in concert with unchanged expression levels of other
superoxide generators or scavengers, our data do not pro-
vide an explanation for the increased mitochondrial
superoxide levels upon Sirt3 deficiency. The extrapolation
that a known Sirt3-dependent impairment of the mito-
chondrial function may enhance mitochondrial superoxide
generation remains speculative and warrants further
investigation.
In addition, we would like to point out that endothelial
dysfunction in Sirt3-/- mice was observed only upon
exposure to a high-cholesterol diet, known to induce
oxidative stress [37]. In vitro, mitochondrial superoxide
accumulation and differential SOD2 regulation upon Sirt3
deficiency was apparent under basal conditions. Though
we assume that this is due to the nature of in vitro setups
in general, extrapolation to our ex vivo data may be
limited.
Moreover, endothelial-dependent vasodilation was
assessed using mouse aortic rings in organ chamber baths,
which is an ex vivo approach. Again, extrapolation to
in vivo vascular function as well as to other species has to
be done with caution.
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Conclusions and implications
The current data indicate a protective role of endogenous
endothelial Sirt3 in mice fed a high-cholesterol diet,
maintaining endothelium-dependent vasorelaxation. The
in vitro findings suggest that a novel C/EBP-b-dependent
rescue mechanism diminishes Sirt3-dependent endothelial
dysfunction under physiological conditions (normal diet).
We have reported Sirt3-mediated protection from accel-
erated weight gain and a decline inmetabolic flexibility [55],
two important risk factors of human cardiovascular diseases
[5]. Our current findings identify an interplay of Sirt3, SOD2,
and C/EBP-b in the endothelial redox system. Endothelial
dysfunction is independently associated with future adverse
cardiovascular events [16, 17, 36, 40, 48]. Further research is
warranted to better understand the putatively protective role
of Sirt3 in human cardiovascular disease.
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